TrustCore Financial Services’s United Therapeutics UTHR Stock Holding History

TrustCore Financial Services’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-50	Closed	-$9K	–	1129
2022 Q1	$9K	Hold	50	–	–	﹤0.01%	786
2021 Q4	$11K	Hold	50	–	–	﹤0.01%	698
2021 Q3	$9K	Hold	50	–	–	﹤0.01%	786
2021 Q2	$9K	Hold	50	–	–	﹤0.01%	770
2021 Q1	$8K	Hold	50	–	–	﹤0.01%	732
2020 Q4	$8K	Hold	50	–	–	﹤0.01%	718
2020 Q3	$5K	Sell	50 -10	-17%	-$1.1K	﹤0.01%	701
2020 Q2	$7K	Hold	60	–	–	﹤0.01%	676
2020 Q1	$6K	Buy	60 +20	+50%	+$1.9K	﹤0.01%	674
2019 Q4	$4K	Buy	+40	New	+$3.52K	﹤0.01%	764
2018 Q3	–	Sell	-16	Closed	-$2K	–	985
2018 Q2	$2K	Buy	+16	New	+$1.76K	﹤0.01%	855

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

TrustCore Financial Services's UTHR Position: Q2 2022 in Review

TrustCore Financial Services sold out of United Therapeutics (UTHR) in Q2 2022, closing a stake of 50 shares — an estimated $9K sold.

TrustCore Financial Services first reported a position in UTHR in Q2 2018 and held it in 11 quarters. The position peaked at $11K in Q4 2021. 472 funds tracked by Wall St. Rank hold UTHR as of Q2 2022.

TrustCore Financial Services reported no remaining United Therapeutics position as of Q2 2022 after selling out during the quarter.
TrustCore Financial Services sold 50 United Therapeutics shares in Q2 2022, an estimated $9K.
TrustCore Financial Services first reported a position in United Therapeutics in Q2 2018 and held it in 11 quarters.
TrustCore Financial Services's United Therapeutics position peaked at $11K in Q4 2021.
472 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2022.

Based on TrustCore Financial Services's 13F filing for Q2 2022, filed 26 Jul 2022.